Skip to main content

Roche’s Virtual Immunology/WCN Investor Event

Roche has hosted a virtual event on 7 February 2025

Agenda
IntroductionBruno Eschli, Head of Investor Relations
Roche immunology kidney pipelineLarry Tsai, Senior Vice President and Global Head of Product Development Immunology
Ph III (REGENCY) Gazyva in lupus nephritis data at WCN 2025Brad H. Rovin, MD, FASN, FACP
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.